NumFin

Body and Mind Inc.

Symbol: BAMM.CN

CNQ

0.095

CAD

Market price today

  • -0.6673

    P/E Ratio

  • -0.0254

    PEG Ratio

  • 14.03M

    MRK Cap

  • 0.00%

    DIV Yield

Body and Mind Inc. (BAMM-CN) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Body and Mind Inc. (BAMM.CN). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Body and Mind Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

01.51.97.4
1.4
9
0.3
0.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

00.91.53.6
2.3
1
0.6
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

02.33.92.9
1.8
1.4
1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

04.60.80.4
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

09.3814.3
5.6
11.6
2
0.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.property-plant-equipment-net

06.29.87.4
6.7
2.7
2.6
0
0
0
0
0.1
0.1
0.1
0
0
0

balance-sheet.row.goodwill

0005.2
2.6
2.6
2.6
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0411.919.9
11.8
8.2
8.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0411.925
14.4
10.8
10.8
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
12.1
11.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01.81.41.4
-33.2
0.1
0
0
0
0
0
0
-0.1
0
0
0
0

balance-sheet.row.total-non-current-assets

011.92333.8
33.2
24.6
13.5
0.1
0
0
0.1
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

021.23148.1
38.8
36.2
15.5
0.5
0
0
0.1
0.1
0.2
0.1
0.1
0
0

balance-sheet.row.account-payables

02.82.51.7
0.8
1
0.4
0.2
0.2
0.2
0.3
0.2
0.1
0
0
0.1
0.2

balance-sheet.row.short-term-debt

01.80.60.8
0.4
0
2.2
0
0.1
0.1
0.1
0
0
0
0.1
0
0

balance-sheet.row.tax-payables

0233.8
1.6
0.2
0.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

018.112.97.1
2.3
0
0
0
0
0
0
0.1
0.1
0.1
0
0
0

Deferred Revenue Non Current

0004.8
0.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00.63.54
1.7
0.3
0.4
0
0
0.6
0.6
0.5
0.2
0
0
0
0

balance-sheet.row.total-non-current-liabilities

022.914.37.3
2.7
1.7
1.7
0
0
0
0
0.1
0.1
0.1
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

096.13.1
2.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

030.520.913.8
5.5
3
4.7
0.2
0.4
0.9
0.9
0.7
0.4
0.2
0.1
0.2
0.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-66.8-45.8-17.1
-14.9
-10.5
-6.8
-4.3
-4
-4.4
-4.2
-3.9
-3.4
-2.1
-1.7
-1.6
-1.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01.51.21.1
0.7
0.8
0.5
0.4
0.3
0.2
0
0
0
-0.1
0
0
0

balance-sheet.row.other-total-stockholders-equity

055.154.250.3
47.7
42.9
17
4.3
3.4
3.4
3.4
3.3
3.3
2.2
1.7
1.4
1.2

balance-sheet.row.total-stockholders-equity

0-10.39.634.3
33.6
33.2
10.8
0.3
-0.3
-0.9
-0.8
-0.6
-0.2
0
0
-0.1
-0.2

balance-sheet.row.total-liabilities-and-stockholders-equity

021.23148.1
38.8
36.2
15.5
0.5
0
0
0.1
0.1
0.2
0.1
0.1
0
0

balance-sheet.row.minority-interest

00.90.50
-0.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0-9.310.134.4
33.3
33.2
10.8
0.3
-0.3
-0.9
-0.8
-0.6
-0.2
0
0
-0.1
-0.2

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
12.1
11.1
0.1
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

019.913.57.9
2.6
0
2.2
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0

balance-sheet.row.net-debt

018.411.70.5
1.3
-9
1.9
-0.4
0.1
0.1
0.1
0.1
0
0
0.1
0
0

Cash Flow Statement

The financial landscape of Body and Mind Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0-20.3-28.2-2
-4.6
-3.8
-1.8
-0.4
0.5
-0.3
-0.3
-0.4
-1.3
-0.4
-0.2
-0.1
-0.1

cash-flows.row.depreciation-and-amortization

01.82.82.3
0.6
0.3
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-0.40.2-0.2
-1.3
-0.1
-1.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00.30.41
1.3
0.9
0.8
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

03.9-0.6-1.2
1.6
-0.4
-0.8
-0.1
0.1
0
0.2
0.3
0.3
0.1
0
0.1
0.1

cash-flows.row.account-receivables

0-0.11.2-0.5
0
-0.4
-0.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

01.3-0.3-0.8
-0.6
-0.4
-0.5
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

00.80.7-0.2
-0.3
0.5
-0.4
0
0
0
0
0.1
0
0
0
0.1
0.1

cash-flows.row.other-working-capital

02-2.10.4
2.5
-0.2
0.4
0
0.1
0
0.2
0.2
0.3
0
0
0
0

cash-flows.row.other-non-cash-items

010.921.90.4
0.1
0.5
0.8
-0.1
-0.6
0
0
0
0.6
0.1
0.1
0
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1-0.8-0.4
-0.9
-0.4
-0.6
0
0
0
0
0
-0.1
-0.1
0
0
0

cash-flows.row.acquisitions-net

00-0.9-0.1
-2.9
-1.9
-2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
-0.3
-6.9
-0.1
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

00.9-0.4-0.4
-1.2
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-0.1-2.1-0.8
-5.3
-9.2
-2.7
-0.1
0
0
0
0
-0.1
-0.1
0
0
0

cash-flows.row.debt-repayment

0-30-5.9
0
-1.4
0
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0000.3
0.1
21.6
4.8
0.9
0
0
0.1
0
0.3
0.3
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

00.505.9
0.1
20.1
0
0
0
0
0
0
0
0.1
0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

03.506.2
0.1
20.1
4.8
0.9
0
0
0.1
0.1
0.4
0.3
0.1
0
0

cash-flows.row.effect-of-forex-changes-on-cash

00.30.10.4
-0.1
0.3
0
0.1
0.1
0.2
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

00-5.56
-7.7
8.7
0
0.4
0
0
0
0
0
0
0
0
0

cash-flows.row.cash-at-end-of-period

01.51.97.4
1.4
9
0.3
0.4
0
0
0
0
0
0
0
0
0

cash-flows.row.cash-at-beginning-of-period

01.57.41.4
9
0.3
0.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.operating-cash-flow

0-3.8-3.40.3
-2.3
-2.6
-2.1
-0.5
-0.1
-0.2
0
-0.1
-0.3
-0.2
-0.1
0
0

cash-flows.row.capital-expenditure

0-1-0.8-0.4
-0.9
-0.4
-0.6
0
0
0
0
0
-0.1
-0.1
0
0
0

cash-flows.row.free-cash-flow

0-4.8-4.3-0.1
-3.2
-2.9
-2.7
-0.5
-0.1
-0.2
0
-0.1
-0.4
-0.3
-0.1
0
0

Income Statement Row

Body and Mind Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of BAMM.CN is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

022.831.625.7
5.3
4.6
2.4
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

01720.713.7
3.8
2.8
1.2
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

05.810.912
1.5
1.8
1.2
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.51.51.5
0.1
0
0.8
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

013.414.511.4
7
4.6
3.2
0.4
0.1
0.2
0.3
0.4
1
0.5
0.2
0.1
0

income-statement-row.row.cost-and-expenses

030.535.225.1
10.8
7.5
4.4
0.4
0.1
0.2
0.3
0.4
1
0.5
0.2
0.1
0

income-statement-row.row.interest-income

00.10.10.2
1.1
0.7
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

01.71.40.1
0.1
1.2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-8.8-22.1-0.4
-0.2
-1.7
-0.7
0
0.6
-0.1
0.1
-0.1
-0.3
0
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.51.51.5
0.1
0
0.8
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

0-8.8-22.1-0.4
-0.2
-1.7
-0.7
0
0.6
-0.1
0.1
-0.1
-0.3
0
0
0
0

income-statement-row.row.interest-expense

01.71.40.1
0.1
1.2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

01.82.52.4
0.6
0.3
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-7.7-3.50.6
-4.3
-2
-2
-0.4
-0.1
-0.2
-0.3
-0.4
-1
-0.5
-0.2
-0.1
0

income-statement-row.row.income-before-tax

0-18.2-25.60.2
-4.5
-3.8
-2.7
-0.4
0.5
-0.3
-0.3
-0.4
-1.3
-0.4
0
-0.1
0

income-statement-row.row.income-tax-expense

02.22.62.2
0.1
1.3
-0.9
0
-0.6
0.1
0
0.1
0.3
0
0
0
0.1

income-statement-row.row.net-income

0-21-28.2-2
-4.6
-5.1
-1.8
-0.4
0.5
-0.3
-0.3
-0.4
-1.3
-0.4
-0.2
-0.1
-0.1
Similar Stocks
You may also be interested in:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Frequently Asked Question

What is Body and Mind Inc. (BAMM.CN) total assets?

Body and Mind Inc. (BAMM.CN) total assets is 21209780.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.346.

What is company free cash flow?

The free cash flow is -0.025.

What is enterprise net profit margin?

The net profit margin is -0.884.

What is firm total revenue?

The total revenue is -0.347.

What is Body and Mind Inc. (BAMM.CN) net profit (net income)?

The net profit (net income) is -21026481.000.

What is firm total debt?

The total debt is 19894824.000.

What is operating expences number?

The operating expences are 13445701.000.

What is company cash figure?

Enretprise cash is 0.000.